Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trials
- Resource Type
- Article
- Source
- In
ESMO Open June 2023 8(3) - Subject
- Language
- ISSN
- 2059-7029